Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3‐adrenoceptor remodelling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3‐adrenoceptor remodelling

Published:2020-12-14 Issue:7 Volume:48 Page:1007-1015
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Audigane Leslie¹,Persello Antoine¹²,Piriou Nicolas¹,Ferron Marine¹,Trochu Jean‐Noël¹,Lauzier Benjamin¹,Gauthier Chantal¹,Rozec Bertrand¹^ORCID

Affiliation:

1. L'institut du thorax INSERM CNRS CHU Nantes Nantes UNIV Nantes Nantes France

2. InFlectis BioScience Nantes France

Funder

Fédération Française de Cardiologie

Fondation France-Japon de l'EHESS

Fondation Daniel Langlois pour l'Art, la Science et la Technologie

Menarini Group

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13447

Reference33 articles.

1. Changes in One-Year Mortality in Elderly Patients Admitted with Acute Myocardial Infarction in Relation with Early Management

2. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure

3. Alteration of the Beta‐Adrenergic Signaling Pathway in Human Heart Failure;Hamdani N;Curr Pharm Biotechnol,2012

4. Nebivolol in the treatment of chronic heart failure;Veverka A;Vasc Health Risk Manag,2007

5. Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-25

2. Neurotransmitters;Biology of Vascular Smooth Muscle;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3